Successful Treatment of Lactobacillus rhamnosus Endocarditis With Intravenous Daptomycin: A Case Report and
Mehboob A Rehan1, J Todd Bagwell2, S Blake Wachter2
1Department of Medicine, Division of Infectious Diseases, Our Lady of Lordes Regional Medical Center, Lafayette, Louisiana, USA.
Abstract:
Lactobacilli are Gram-positive, facultatively aerobic, rod-shaped bacteria that are a normal part of the human microbiota and rarely cause infections in immunocompetent hosts. Lactobacillus casei and Lactobacillus rhamnosus are the most common human pathogens within this genus and are also frequently used in probiotics. Both species are inherently resistant to vancomycin, and penicillin-sometimes in combination with aminoglycosides-remains the primary treatment for infections caused by these organisms. Management becomes particularly challenging in patients with severe penicillin allergies, such as anaphylaxis. Although daptomycin has demonstrated in vitro activity against these pathogens, clinical data on its use are limited. Here, we present a case of Lactobacillus rhamnosus endocarditis successfully treated with 6 weeks of intravenous daptomycin.
Related Concept Videos
Ecological Succession
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Endocarditis III: Medical Management


